Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa

[1]  L. Montaner,et al.  Diverse and High Prevalence of Human Papillomavirus Associated with a Significant High Rate of Cervical Dysplasia in Human Immunodeficiency Virus–Infected Women in Johannesburg, South Africa , 2009, Acta Cytologica.

[2]  Jennifer S. Smith,et al.  HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy , 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[3]  J. Palefsky,et al.  HPV types present in invasive cervical cancers of HIV‐seropositive women , 2008, International journal of cancer.

[4]  C. Poole,et al.  Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. , 2008, American journal of epidemiology.

[5]  L. Myer,et al.  Human Papillomavirus Infection and Cervical Disease in Human Immunodeficiency Virus-1–Infected Women , 2008, Obstetrics and gynecology.

[6]  S. Franceschi,et al.  Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update , 2007, International journal of cancer.

[7]  S. Vermund,et al.  Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. , 2006, Gynecologic oncology.

[8]  S. Franceschi,et al.  Human papillomavirus types among women infected with HIV: a meta-analysis , 2006, AIDS.

[9]  S. Marshall,et al.  Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus , 2006, International journal of cancer.

[10]  F. Bray,et al.  Chapter 2: The burden of HPV-related cancers. , 2006, Vaccine.

[11]  K. Holmes,et al.  Condom Use and the Risk of Genital Human Papillomavirus Infection in Young Women , 2006, The New England journal of medicine.

[12]  W. Cates,et al.  Condoms and sexually-transmitted infections. , 2006, The New England journal of medicine.

[13]  Cosette M Wheeler,et al.  Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. , 2005, The Lancet. Oncology.

[14]  K. Anastos,et al.  Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. , 2005, Journal of the National Cancer Institute.

[15]  Daron G Ferris,et al.  Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial , 2004, The Lancet.

[16]  A. Moscicki,et al.  Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type. , 2004, The Journal of infectious diseases.

[17]  K. Holmes,et al.  Effectiveness of condoms in preventing sexually transmitted infections. , 2004, Bulletin of the World Health Organization.

[18]  H. Cronje,et al.  Screening for cervical cancer in developing countries , 2004, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[19]  A. Barros,et al.  Bmc Medical Research Methodology Open Access Alternatives for Logistic Regression in Cross-sectional Studies: an Empirical Comparison of Models That Directly Estimate the Prevalence Ratio Cox Regressioncross-sectional Studieslogistic Regressionodds Ratiopoisson Regressionprevalence Ratiorobust Varia , 2022 .

[20]  M. B. Diouf,et al.  Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. , 2003, Journal of Infectious Diseases.

[21]  K. Anastos,et al.  Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. , 2003, Journal of the National Cancer Institute.

[22]  K. Shah,et al.  Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. , 2003, The Journal of infectious diseases.

[23]  F. X. Bosch,et al.  Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.

[24]  S. Vansteelandt,et al.  Distribution of Human Papillomavirus in a Family Planning Population in Nairobi, Kenya , 2003, Sexually transmitted diseases.

[25]  Z. Chirenje,et al.  Association of cervical SIL and HIV-1 infection among Zimbabwean women in an HIV/STI prevention study , 2002, International journal of STD & AIDS.

[26]  Mark Sherman,et al.  The 2001 Bethesda System: terminology for reporting results of cervical cytology. , 2002, JAMA.

[27]  C J L M Meijer,et al.  The causal relation between human papillomavirus and cervical cancer. , 2002, Journal of clinical pathology.

[28]  M. Chiasson,et al.  HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study , 2002, The Lancet.

[29]  L. Ahdieh,et al.  The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women , 2001, AIDS.

[30]  A. Lazzarin,et al.  Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. , 2001, The Journal of infectious diseases.

[31]  P. Vernazza,et al.  Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression , 2000 .

[32]  M. Chiasson,et al.  Incidence of cervical squamous intraepithelial lesions in HIV-infected women. , 2000, JAMA.

[33]  J. Peto,et al.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.

[34]  L. Kalish,et al.  Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. , 1999, Journal of the National Cancer Institute.

[35]  L Beardsley,et al.  Natural history of cervicovaginal papillomavirus infection in young women. , 1998, The New England journal of medicine.

[36]  M. Kazatchkine,et al.  Early regression of cervical lesions in HIV‐seropositive women receiving highly active antiretroviral therapy , 1998, AIDS.

[37]  G. Orth,et al.  Comparative prevalence, incidence and short‐term prognosis of cervical squamous intraepithelial lesions amongst HIV‐positive and HIV‐negative women , 1998, AIDS.

[38]  J. Feldman,et al.  A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women. , 1998, American journal of obstetrics and gynecology.

[39]  H S Sacks,et al.  Meta-analysis: an update. , 1996, The Mount Sinai journal of medicine, New York.

[40]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[41]  S. Franceschi,et al.  Human papillomavirus types in women with invasive cervical carcinoma by HIV status in Kenya , 2008, International journal of cancer.

[42]  R. Hayes,et al.  Cancer Causes & Control , 2004, Cancer Causes & Control.

[43]  K. Shah,et al.  Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection. , 2002, American journal of obstetrics and gynecology.

[44]  R. Rajkumar,et al.  Effective screening programmes for cervical cancer in low- and middle-income developing countries. , 2001, Bulletin of the World Health Organization.